Europe in-vitro diagnostics market was valued at US$ 24.13 billion in 2022 and is projected to attain a market size of US$ 35.22 billion by 2031 at a CAGR of 4.5% during the forecast period 2023–2031.
Global clinical trials support service market was valued at US$ 23.8 billion in 2022 and is projected to surpass US$ 44.5 billion by 2031 at a CAGR of 7.22% during the forecast period 2023–2031.
North America ECG patch and Holter monitoring market was valued at US$ 1,161.4 million in 2022 and is projected to surpass the market valuation of US$ 4,413.3 million by 2031 at a CAGR of 15.99% during the forecast period 2023–2031.
Global hand, foot, and mouth disease treatment market was valued at US$ 2,900.6 million in 2022 and is projected to generate a revenue of US$ 4,942.2 million by 2031 at a CAGR of 6.1% during the forecast period 2023–2031.
Global plant stem cells market was valued at US$ 371.4 million in 2022 and is projected to attain a valuation of US$ 801.9 million by 2031 at a CAGR of 8.93% during the forecast period 2023-2031.
Japan pharmaceutical manufacturing market was valued at US$ 31.74 billion in 2022 and is projected to reach market size of US$ 53.90 billion by 2031 at a CAGR of 6.06% during the forecast period 2023–2031.
Global pharmaceutical manufacturing market was valued at US$ 785.8 billion in 2022 and is projected to reach market size of US$ 2,103.2 billion by 2031 at a CAGR of 11.56% during the forecast period 2023–2031.
Global ultrasound devices market was valued at US$ 7,197.7 million in 2022 and is projected to reach US$ 10,919.6 million by 2031 at a CAGR of 4.74% during the forecast period 2023–2030 during the forecast period 2023–2031.
United States liquid biopsy market was valued at US$ 3,405.8 million in 2022 and is projected to surpass market valuation of US$ 10,798 million by 2031 at a CAGR of 13.68% during the forecast period 2023–2031.